XML 16 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Total
Balance at Mar. 31, 2021 $ 223 $ 63,650 $ 87,881 $ (160) $ 151,594
Balance (in shares) at Mar. 31, 2021 22,351,235        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income     12,185   12,185
Cash dividend on common stock     (2,338)   (2,338)
Exercise of stock options   17 (1)   $ 16
Exercise of stock options (in shares) 6,000       6,000
Stock repurchased $ (2) (1,722)     $ (1,724)
Stock repurchased (in shares) (249,908)        
Restricted stock grants (in shares) 57,380        
Stock-based compensation expense   177     177
Other comprehensive loss, net       (150) (150)
Balance at Sep. 30, 2021 $ 221 62,122 97,727 (310) 159,760
Balance (in shares) at Sep. 30, 2021 22,164,707        
Balance at Jun. 30, 2021 $ 222 63,213 92,522 1,019 156,976
Balance (in shares) at Jun. 30, 2021 22,277,868        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income     6,430   6,430
Cash dividend on common stock     (1,224)   (1,224)
Exercise of stock options   17 (1)   16
Exercise of stock options (in shares) 6,000        
Stock repurchased $ (1) (1,230)     (1,231)
Stock repurchased (in shares) (176,541)        
Restricted stock grants (in shares) 57,380        
Stock-based compensation expense   122     122
Other comprehensive loss, net       (1,329) (1,329)
Balance at Sep. 30, 2021 $ 221 62,122 97,727 (310) 159,760
Balance (in shares) at Sep. 30, 2021 22,164,707        
Balance at Mar. 31, 2022 $ 221 62,048 104,931 (9,951) 157,249
Balance (in shares) at Mar. 31, 2022 22,127,396        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income     9,846   9,846
Cash dividend on common stock     (2,610)   (2,610)
Exercise of stock options   4     $ 4
Exercise of stock options (in shares) 1,511       1,511
Stock repurchased $ (7) (4,777)     $ (4,784)
Stock repurchased (in shares) (690,494)        
Restricted stock grants and forfeited, net (in shares) 68,719        
Stock-based compensation expense   192     192
Purchase of subsidiary shares from noncontrolling interest   (234)     (234)
Other comprehensive loss, net       (12,501) (12,501)
Balance at Sep. 30, 2022 $ 214 57,233 112,167 (22,452) 147,162
Balance (in shares) at Sep. 30, 2022 21,507,132        
Balance at Jun. 30, 2022 $ 219 60,838 108,266 (14,890) 154,433
Balance (in shares) at Jun. 30, 2022 21,943,160        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income     5,194   5,194
Cash dividend on common stock     (1,293)   (1,293)
Stock repurchased $ (5) (3,500)     (3,505)
Stock repurchased (in shares) (507,724)        
Restricted stock grants (in shares) 71,696        
Stock-based compensation expense   129     129
Purchase of subsidiary shares from noncontrolling interest   (234)     (234)
Other comprehensive loss, net       (7,562) (7,562)
Balance at Sep. 30, 2022 $ 214 $ 57,233 $ 112,167 $ (22,452) $ 147,162
Balance (in shares) at Sep. 30, 2022 21,507,132